On this page
SLC4A1
solute carrier family 4 member 1 (Diego blood group)
SLC4A1 is located on the long (q) arm of chromosome 17, at band 17q21.31. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 17 in the library →Available at Jeen Health
Clinical tests that include this
Overview
SLC4A1 resides on chromosome 17 and directs synthesis of anion exchanger 1, a chloride-bicarbonate transporter found predominantly in red blood cells and specialised kidney cells. The gene produces two distinct protein isoforms differing in length: a longer form in erythrocytes and a shorter variant in renal alpha-intercalated cells. Both isoforms facilitate the movement of negatively charged ions across cell membranes, a process critical for maintaining physiological pH.
Pathogenic variants in SLC4A1 underlie several inherited conditions affecting either blood cells or kidney function. When the red blood cell isoform is disrupted, individuals may develop hereditary spherocytosis, characterised by fragile, sphere-shaped erythrocytes. Defects affecting the kidney isoform typically result in distal renal tubular acidosis, where the kidneys cannot properly eliminate acid into the urine. The gene follows autosomal recessive inheritance for renal conditions and autosomal dominant inheritance for certain haematological disorders.
What the gene does
Anion exchanger 1 operates as a chloride-bicarbonate antiporter, coupling the movement of chloride ions in one direction with bicarbonate ions in the opposite direction across the cell membrane. This electroneutral exchange does not require energy input but relies on existing ion concentration gradients. The primary physiological role is acid-base homeostasis: by controlling bicarbonate distribution, AE1 helps cells and tissues regulate their internal pH within narrow limits compatible with life.
In renal alpha-intercalated cells lining the distal tubules and collecting ducts, the shorter AE1 isoform resides at the basolateral membrane. Here it mediates bicarbonate exit from the cell into the bloodstream, enabling the cell to secrete hydrogen ions into the urine and thus eliminate metabolic acid from the body. In red blood cells, the longer isoform serves dual functions: it facilitates rapid gas exchange by allowing bicarbonate produced from carbon dioxide in tissues to exit the cell in exchange for chloride, and it anchors cytoskeletal proteins including ankyrin-1 to maintain erythrocyte shape and mechanical resilience during circulation through narrow capillaries.
Video: Genetics 101
Chromosome location
SLC4A1 maps to chromosomal band 17q21.31 on the long arm of chromosome 17. The gene spans approximately 20 kilobases of genomic DNA and contains 20 exons. Alternative splicing of the primary transcript produces the two principal isoforms: translation initiation at the first methionine yields the full-length 911-amino-acid erythrocyte form, whilst initiation at a downstream methionine in kidney cells generates a truncated protein lacking the N-terminal cytoplasmic domain.
Protein structure
The full-length anion exchanger 1 protein comprises 911 amino acids organised into distinct functional regions. The N-terminus features a disordered region spanning amino acids 1-40, followed by a globular domain extending from residues 55-290 that participates in cytoskeletal interactions. An interaction site with ankyrin-1 (ANK1) is located between amino acids 176-185, critical for anchoring the protein to the red blood cell membrane skeleton. A dimerisation arm occupies residues 304-357, facilitating the formation of AE1 dimers and higher-order complexes within the membrane.
The membrane-spanning portion contains the anion transport machinery concentrated in the region from amino acids 559-630, where the chloride-bicarbonate exchange activity resides. The C-terminal cytoplasmic tail includes a segment (amino acids 720-761) termed the 5ABC region. Notably, specific regions of AE1 serve as binding sites for malaria parasites: residues 13-31 interact with fructose-bisphosphate aldolase from Plasmodium falciparum isolate K1, whilst the 5ABC region binds merozoite surface protein 9 from the 3D7 isolate, highlighting the protein's role in host-pathogen interactions.
Key variants
Pathogenic variants in SLC4A1 encompass missense substitutions, small deletions, and splice-site alterations distributed across the gene. Variants affecting the membrane transport domain typically impair ion exchange function, whilst those disrupting the cytoplasmic regions often interfere with protein trafficking or cytoskeletal binding. The inheritance pattern and clinical phenotype depend on variant location and functional consequence: dominant variants affecting red blood cell morphology contrast with recessive variants predominantly impairing renal acid secretion.
No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.
Associated conditions
SLC4A1 pathogenic variants cause a spectrum of conditions affecting erythrocytes and renal tubular function. Hereditary spherocytosis results from dominant variants that reduce AE1 expression or disrupt its structural role in red blood cells, leading to spherical, osmotically fragile erythrocytes prone to premature destruction and haemolytic anaemia. Distal renal tubular acidosis arises when recessive variants compromise the kidney isoform's ability to facilitate bicarbonate reabsorption, resulting in metabolic acidosis, hypokalaemia, and nephrocalcinosis. Some individuals with renal acidosis also manifest blood cell abnormalities including Southeast Asian ovalocytosis or hereditary stomatocytosis, reflecting overlapping functional domains.
Inheritance pattern
Conditions caused by pathogenic SLC4A1 variants typically follow autosomal dominant inheritance.
Each child has a 50% chance of inheriting the pathogenic variant, regardless of sex.
UK clinical status
SLC4A1 holds green classification on multiple NHS Genomic Medicine Service gene panels, reflecting strong evidence for clinical validity in defined conditions. The gene appears on the Cytopenias and congenital anaemias panel and the Rare anaemia panel (R92), supporting its role in inherited haematological disorders. Inclusion on the Renal tubulopathies panel (R198) and the Nephrocalcinosis or nephrolithiasis panel (R256) recognises the gene's involvement in distal renal tubular acidosis. Green status on the DDG2P panel confirms its relevance to developmental disorders affecting multiple systems.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What is the difference between the two forms of AE1 protein?
The longer form contains 911 amino acids and is found in red blood cells, where it functions both as an ion exchanger and a structural anchor for the cell membrane skeleton. The shorter kidney form lacks the N-terminal cytoplasmic domain and resides in renal tubule cells, where it exclusively performs ion exchange to regulate acid secretion into urine.
Why do some SLC4A1 variants cause kidney problems whilst others affect blood cells?
Variants affecting the membrane transport domain often impair kidney function because renal acid secretion critically depends on ion exchange activity. Variants disrupting the N-terminal cytoplasmic region or reducing overall protein levels preferentially affect red blood cells, where AE1 serves a structural role linking the membrane to the underlying cytoskeleton. Some variants impact both systems, causing combined renal and haematological features.
Is SLC4A1 tested on the NHS for hereditary spherocytosis?
Yes, SLC4A1 is included on NHS gene panels for congenital anaemias and cytopenias with green classification, meaning there is strong evidence supporting its clinical use in diagnosing hereditary spherocytosis and related blood disorders through the NHS Genomic Medicine Service.
References
- Batlle D, Haque SK. Genetic causes and mechanisms of distal renal tubular acidosis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2012. PMID: 23114896
- Ungsupravate D, Sawasdee N, Khositseth S. Impaired trafficking and intracellular retention of mutant kidney anion exchanger 1 proteins (G701D and A858D) associated with distal renal tubular acidosis. Molecular membrane biology. 2010. PMID: 20151848
- Alper SL. Molecular physiology and genetics of Na+-independent SLC4 anion exchangers. The Journal of experimental biology. 2009. PMID: 19448077
- Khositseth S, Sirikanaerat A, Khoprasert S. Hematological abnormalities in patients with distal renal tubular acidosis and hemoglobinopathies. American journal of hematology. 2008. PMID: 18266205
- Cordat E, Kittanakom S, Yenchitsomanus PT. Dominant and recessive distal renal tubular acidosis mutations of kidney anion exchanger 1 induce distinct trafficking defects in MDCK cells. Traffic (Copenhagen, Denmark). 2006. PMID: 16420521
- Cheung JC, Cordat E, Reithmeier RA. Trafficking defects of the Southeast Asian ovalocytosis deletion mutant of anion exchanger 1 membrane proteins. The Biochemical journal. 2005. PMID: 16107207
- Yenchitsomanus PT, Kittanakom S, Rungroj N. Molecular mechanisms of autosomal dominant and recessive distal renal tubular acidosis caused by SLC4A1 (AE1) mutations. Journal of molecular and genetic medicine : an international journal of biomedical research. 2005. PMID: 19565014
- Jarolim P, Murray JL, Rubin HL. Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency. Blood. 1996. PMID: 8943874